Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peyton Schumacher
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5111108307
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphoma
2024
·
Chonlada Laoruangroj
, Pamela J. Atherton
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
4
PDF
Impact of race and social deprivation on outcomes with modern day induction therapy in patients with newly diagnosed multiple myeloma: An ASH research collaborative data hub analysis
2025
·
Hamza Hashmi
, Meera Mohan
, et al.
·
Blood
PDF
Defining functional high-risk multiple myeloma in the era of modern induction therapy
2025
·
Barry Paul
, Carlyn Tan
, et al.
·
Blood
Show more works
View as search
Works count:
3
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type
